Spliced X-Box binding protein 1 predicts satisfying responsiveness and survival benefit toward bortezomib-based therapy in multiple myeloma patients

Spliced X-Box binding protein 1 predicts satisfying responsiveness and survival benefit toward bortezomib-based therapy in multiple myeloma patients

Objective Spliced X-Box binding protein 1 (sXBP1) modulates malignant cell activities and enhances the bortezomib sensitivity in multiple myeloma (MM) cells, while its clinical value in MM patients remains elusive. Hence, the current study aimed to explore this issue, particularly the correlation of...

Full description

Bibliographic Details
Main Authors: Lingli Zhang, Jichang Gong, Li Yaqiong
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Hematology
Subjects:
Multiple myeloma
spliced X-Box binding protein 1
clinical features
bortezomib
survival profile
Online Access:https://www.tandfonline.com/doi/10.1080/16078454.2022.2117123

Internet

https://www.tandfonline.com/doi/10.1080/16078454.2022.2117123

Similar Items